¼¼°èÀÇ Á¶Á÷ Ŭ¸®¾î¸µ ½ÃÀå
Tissue Clearing
»óǰÄÚµå : 1777626
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 467 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,204,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,612,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ Á¶Á÷ Ŭ¸®¾î¸µ ½ÃÀåÀº 2030³â±îÁö 1¾ï 9,720¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 1¾ï 1,860¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ Á¶Á÷ Ŭ¸®¾î¸µ ½ÃÀåÀº 2024-2030³â¿¡ CAGR 8.8%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 1¾ï 9,720¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ÀνºÆ®·ç¸ÕÆ®´Â CAGR 10.0%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 1¾ï 2,210¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ŰƮ & ½Ã¾à ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 7.5%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ÃßÁ¤ 3,230¸¸ ´Þ·¯, Áß±¹Àº CAGR 13.9%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ Á¶Á÷ Ŭ¸®¾î¸µ ½ÃÀåÀº 2024³â¿¡´Â 3,230¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 4,350¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 13.9%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 4.4%¿Í 8.5%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 5.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Á¶Á÷ Ŭ¸®¾î¸µ ½ÃÀåÀÇ µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

Á¶Á÷ Ŭ¸®¾î¸µÀº ¹ÙÀÌ¿À¸ÞµðÄà À̹Ì¡°ú ½Å°æ°úÇÐ ¿¬±¸¿¡ ¾î¶² Çõ¸íÀ» ÀÏÀ¸Å°°í Àִ°¡?

Á¶Á÷ Ŭ¸®¾î¸µÀº ±âÁ¸ÀÇ ÀýÆíÈ­ ±â¼ú ¾øÀ̵µ ½ÉºÎÁ¶Á÷ÀÇ ±¸Á¶¸¦ 3Â÷¿øÀûÀ¸·Î »ó¼¼ÇÏ°Ô ½Ã°¢È­ÇÔÀ¸·Î½á »ýÀÇÇÐ ¿¬±¸¿¡ Çõ½ÅÀ» °¡Á®¿É´Ï´Ù. ÀÌ °úÁ¤Àº ½Å°æ°úÇÐ, ¾Ï ¿¬±¸, ¹ß»ý»ý¹°Çп¡ ¸Å¿ì Áß¿äÇϸç, ¿¬±¸ÀÚµéÀº Àå±â Àüü¿Í º¹ÀâÇÑ ¼¼Æ÷ ³×Æ®¿öÅ©¸¦ ±× ¾î´À ¶§º¸´Ù ¸í·áÇÏ°Ô ¿¬±¸ÇÒ ¼ö ÀÖ½À´Ï´Ù. CLARITY, CUBIC, iDISCO¿Í °°Àº ÇÏÀ̵å·Î°Ö ±â¹Ý ¹× ¿ë¸Å ±â¹Ý Á¶Á÷ Ŭ¸®¾î¸µ ¹æ¹ýÀÇ ¹ßÀüÀ¸·Î À̹Ì¡ ÇØ»óµµ¿Í Á¶Á÷ Åõ¸íµµ°¡ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. Á¶Á÷ Ŭ¸®¾î¸µ°ú ¶óÀÌÆ® ½ÃÆ® Çü±¤ Çö¹Ì°æ(LSFM)ÀÇ ÅëÇÕ ¹× AI¸¦ ÅëÇÑ À̹ÌÁö ºÐ¼®À¸·Î Áúº´ ¸ðµ¨¸µ°ú ½Å¾à°³¹ß¿¡ ´ëÇÑ ÀÀ¿ëÀÌ ´õ¿í ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ½Ã·á ó¸®ÀÇ º¹À⼺, ºñ¿ë, Ç¥ÁØÈ­ ¹®Á¦ µîÀÇ °úÁ¦´Â ¿©ÀüÈ÷ º¸±ÞÀÇ À庮À¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. Á¤¹ÐÀÇ·á¿Í Á¶Á÷°øÇÐÀÌ ¹ßÀüÇÏ´Â °¡¿îµ¥, Á¶Á÷ Ŭ¸®¾î¸µÀº ¾î¶»°Ô ¹ÙÀÌ¿À À̹Ì¡À» ÀçÁ¤ÀÇÇÏ°í °úÇÐÀû µ¹ÆÄ±¸¸¦ °¡¼ÓÈ­ÇÒ ¼ö Àִ°¡?

¾î¶² ±â¼ú Çõ½ÅÀÌ Á¶Á÷ Ŭ¸®¾î¸µÀ» ¹ßÀü½Ã۰í Àִ°¡?

ÃÖ±Ù Á¶Á÷ Ŭ¸®¾î¸µ ±â¼úÀÇ Çõ½ÅÀº Åõ¸í¼º È¿À²À» ³ôÀ̰í, ó¸® ½Ã°£À» ´ÜÃàÇϸç, Çü±¤ ¸¶Ä¿¿ÍÀÇ È£È¯¼ºÀ» Çâ»ó½ÃÄ×½À´Ï´Ù. AI ±â¹Ý À̹ÌÁö À籸¼º ÅøÀº 3D µ¥ÀÌÅÍ ºÐ¼®À» °£¼ÒÈ­Çϰí, ¼¼Æ÷ ±¸Á¶¸¦ º¸´Ù Á¤È®ÇÏ°Ô ½Ã°¢È­ÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. µ¶¼ºÀ» ÁÙÀ̰í Á¶Á÷ º¸Á¸¼ºÀ» Çâ»ó½ÃŲ »õ·Î¿î Ŭ¸®¾î¸µ ½Ã¾àÀº Àå±âÀûÀÎ »ý¹°ÇÐÀû ¿¬±¸¿¡ ´ëÇÑ ÀÀ¿ëÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù. Á¶Á÷ Ŭ¸®¾î¸µ°ú ÃÊÇØ»óµµ Çö¹Ì°æÀ» °áÇÕÇÏ¿© ½Å°æÁ¶Á÷À̳ª ¾ÏÁ¶Á÷ÀÇ ³ª³ë ½ºÄÉÀÏ À̹Ì¡ÀÌ °¡´ÉÇÕ´Ï´Ù. ¶ÇÇÑ ÀÚµ¿È­µÈ Á¶Á÷ Ŭ¸®¾î¸µ Ç÷§ÆûÀº ¼öÀÛ¾÷À¸·Î ÀÎÇÑ Ã³¸®ÀÇ ¹ø°Å·Î¿òÀ» ÁÙÀ̰í, ½ÇÇè½Ç¿¡¼­ÀÇ °í󸮷® ¿¬±¸¸¦ º¸´Ù Çö½ÇÀûÀ¸·Î ¸¸µé¾î ÁÝ´Ï´Ù.

Á¶Á÷ Ŭ¸®¾î¸µ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

½Å°æ°úÇÐ ¿¬±¸¿¡ ´ëÇÑ °ü½É Áõ°¡, ¾Ï Áø´Ü¿¡¼­ 3D À̹Ì¡ÀÇ »ç¿ë Áõ°¡, »ý¹° ÀÇÇÐ ¿¬±¸¿¡¼­ Àüü Àå±â À̹Ì¡¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â Á¶Á÷ Ŭ¸®¾î¸µÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Á¦¾à¾÷°èµµ Á¶Á÷ Ŭ¸®¾î¸µ ±â¼úÀ» Ȱ¿ëÇÏ¿© ÀǾàǰ °³¹ß ÇÁ·Î¼¼½º °³¼± ¹× Ä¡·á Ç¥Àû °ËÁõ¿¡ Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àç»ýÀÇ·á ¹× Á¶Á÷°øÇп¡ ´ëÇÑ Àû¿ë È®´ë°¡ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Á¶Á÷ Ŭ¸®¾î¸µ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

¿µ»ó ó¸® ±â¼úÀÇ ¹ßÀü, ½Å°æ°úÇÐ ¹× Á¾¾çÇÐ ºÐ¾ß¿¡¼­ÀÇ ÀÀ¿ë Áõ°¡, »ýÀÇÇÐ ¿¬±¸¿¡ ´ëÇÑ Á¤ºÎ ÀÚ±Ý Áö¿ø Áõ°¡, AI Áö¿ø ¿µ»ó ó¸®ÀÇ °³¼± µîÀ¸·Î ½ÃÀåÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. »ý¸í°úÇÐ ¹× ÀÇÇÐ ¿¬±¸°¡ ¼¼Æ÷ ½Ã°¢È­ÀÇ ÇѰ踦 °è¼Ó ³ÐÇô°¡°í ÀÖ´Â °¡¿îµ¥, Á¶Á÷ Ŭ¸®¾î¸µÀº Á¤¹ÐÀÇ·á¿Í Áúº´ ¸ðµ¨¸µÀÇ ¹ßÀü¿¡ ÇʼöÀûÀÎ ÅøÀÌ µÉ °ÍÀ¸·Î ±â´ëµÇ°í ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(¿¬Á¶Á÷, °æÁ¶Á÷), ¿ëµµ(½Å°æÇÐ, Á¾¾çÇÐ, ½ÉÀ庴ÇÐ, ±âŸ), ÃÖÁ¾ ¿ëµµ(Çмú¿¬±¸, »ê¾÷).

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

´ç»ç´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Tissue Clearing Market to Reach US$197.2 Million by 2030

The global market for Tissue Clearing estimated at US$118.6 Million in the year 2024, is expected to reach US$197.2 Million by 2030, growing at a CAGR of 8.8% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$122.1 Million by the end of the analysis period. Growth in the Kits & Reagents segment is estimated at 7.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$32.3 Million While China is Forecast to Grow at 13.9% CAGR

The Tissue Clearing market in the U.S. is estimated at US$32.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$43.5 Million by the year 2030 trailing a CAGR of 13.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.4% and 8.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.9% CAGR.

Tissue Clearing Market Trends & Drivers Summarized

How Is Tissue Clearing Revolutionizing Biomedical Imaging and Neuroscience Research?

Tissue clearing is transforming biomedical research by enabling the visualization of deep-tissue structures in three-dimensional detail without the need for traditional sectioning techniques. This process is critical for neuroscience, cancer research, and developmental biology, as it allows researchers to study entire organs and complex cellular networks with unprecedented clarity. Advances in hydrogel-based and solvent-based tissue clearing methods, such as CLARITY, CUBIC, and iDISCO, are improving imaging resolution and tissue transparency. The integration of tissue clearing with light-sheet fluorescence microscopy (LSFM) and AI-driven image analysis is further enhancing its application in disease modeling and drug discovery. However, challenges such as sample processing complexity, cost, and standardization issues remain barriers to widespread adoption. As precision medicine and tissue engineering advance, how will tissue clearing redefine biological imaging and accelerate scientific breakthroughs?

What Technological Innovations Are Advancing Tissue Clearing?

Recent innovations in tissue clearing techniques are enhancing transparency efficiency, reducing processing times, and improving compatibility with fluorescent markers. AI-powered image reconstruction tools are streamlining 3D data analysis, allowing for more accurate visualization of cellular structures. Novel clearing reagents with reduced toxicity and improved tissue preservation are expanding applications in long-term biological studies. The combination of tissue clearing with super-resolution microscopy is enabling nanoscale imaging of neural and cancerous tissues. Additionally, automated tissue clearing platforms are reducing manual processing efforts, making high-throughput studies more feasible in research laboratories.

Why Is the Demand for Tissue Clearing Increasing?

The growing focus on neuroscience research, increasing use of 3D imaging in cancer diagnostics, and rising demand for whole-organ imaging in biomedical studies are driving the adoption of tissue clearing. The pharmaceutical industry is also leveraging tissue clearing techniques to improve drug development processes and validate therapeutic targets. Additionally, the expansion of regenerative medicine and tissue engineering applications is further fueling demand.

What Factors Are Driving the Growth of the Tissue Clearing Market?

The market is expanding due to advancements in imaging technologies, increasing applications in neuroscience and oncology, rising government funding for biomedical research, and improvements in AI-assisted image processing. As life sciences and medical research continue to push the boundaries of cellular visualization, tissue clearing is expected to become an integral tool for advancing precision medicine and disease modeling.

SCOPE OF STUDY:

The report analyzes the Tissue Clearing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Instruments, Kits & Reagents, Services); Tissue Type (Soft Tissue, Hard Tissue); Application (Neurology, Oncology, Cardiology, Others); End-Use (Academic Research, Industrial)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â